Postoperative ctDNA monitoring: a canary in a coalmine
- PMID: 33484835
- DOI: 10.1016/j.annonc.2021.01.005
Postoperative ctDNA monitoring: a canary in a coalmine
Conflict of interest statement
Disclosure YYJ has received research funding provided to the institution from Rgenix, Boehringer Ingelheim, Bayer, Genentech/Roche, Bristol-Myers Squibb, Eli Lilly, and Merck; served on advisory boards for Rgenix, Merck Serono, Bristol-Myers Squibb, Eli Lilly, Pfizer, Bayer, Imugene, Merck, Daiichi-Sankyo, Zymeworks, Basilea Pharmaceutica, and AstraZeneca; and holds stock options for Rgenix. The remaining authors have declared no conflicts of interest.
Comment on
-
Longitudinal tracking of 97 esophageal adenocarcinomas using liquid biopsy sampling.Ann Oncol. 2021 Apr;32(4):522-532. doi: 10.1016/j.annonc.2020.12.010. Epub 2021 Jan 7. Ann Oncol. 2021. PMID: 33359547
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
